Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection

QR Code

Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection

Francis J Zamora,1,2 Ellen Dowers,2 Faiza Yasin,3 Onyema Ogbuagu3 1Department of Pharmacy Services, Broward Health Medical Center, Fort Lauderdale, FL, USA; 2Department of Pharmacy Services, Yale-New Haven Hospital, New Haven, CT, USA; 3Section of Infectious Diseases, Yale AIDS Program, Yale Univers...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Zamora FJ, Dowers E, Yasin F, Ogbuagu O
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2019
Sujets:	dolutegravir lamivudine combination antiretroviral therapy Immunologic diseases. Allergy RC581-607
Accès en ligne:	https://doaj.org/article/134e70daf0d848d3b33efb2378bc5b49
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Dolutegravir/rilpivirine for the treatment of HIV-1 infection
par: Dowers E, et autres
Publié: (2018)

EXPERIENCE WITH DOLUTEGRAVIR IN HIV PATIENTS AT A PUBLIC SECTOR HOSPITAL IN KARACHI, PAKISTAN
par: Farzana Batool, et autres
Publié: (2021)

Profile of once-daily darunavir/cobicistat fixed-dose combination for the treatment of HIV/AIDS
par: Navarro J, et autres
Publié: (2016)

Effect of Lamivudine on the Rat Pregnancy Outcome
par: Pontes,Rosana Dorsa Vieira, et autres
Publié: (2005)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
par: Dubrocq G, et autres
Publié: (2018)

Factors associated with antiretroviral therapy adherence among people living with HIV in Haiti: a cross-sectional study
par: Ludentz Dorcélus, et autres
Publié: (2021)

Antiretroviral Treatment Adherence and Determinant Factors Among Adult People Infected with Human Immunodeficiency Virus in Eastern Tigray General Hospitals, Northern Ethiopia, 2019
par: Gebreagziabher TT, et autres
Publié: (2020)

Prevalence and Factors Associated with Delayed Initiation of Antiretroviral Therapy Among People Living with HIV in Nekemte Referral Hospital, Western Ethiopia
par: Bayisa L, et autres
Publié: (2020)

Profile of cabotegravir and its potential in the treatment and prevention of HIV-1 infection: evidence to date
par: Whitfield T, et autres
Publié: (2016)

Evaluating cabotegravir/rilpivirine long-acting, injectable in the treatment of HIV infection: emerging data and therapeutic potential
par: Fernandez C, et autres
Publié: (2019)

The Effect of Moderate- and High-Fat Meals on the Bioavailability of Dolutegravir/Rilpivirine Fixed-Dose Combination Tablet
par: Mehta R, et autres
Publié: (2020)

Elevation of immunoglobulin levels is associated with treatment failure in HIV-infected children in Vietnam
par: Dang LVP, et autres
Publié: (2018)

CLINICAL EFFICIENCY AND INFLUENCE OF COMBINED ANTIHYPERTENSIVE THERAPY UPON CYTOKINE PROFILE IN THE PATIENTS WITH ARTERIAL HYPERTENSION
par: T. A. Dronova, et autres
Publié: (2014)

ROLE OF HEPATITIS C VIRUS COINFECTION IN VIOLATION OF PRODUCTIVE THYMIC FUNCTION IN HIV-INFECTED PATIENTS UNDER IMMUNOLOGICALLY INEFFICIENT ANTIRETROVIRAL THERAPY
par: E. V. Saidakova, et autres
Publié: (2014)

Experiences and Lessons Learnt from the HIV Treat All Pilot Phase Implementation in Zimbabwe
par: Makurumidze R
Publié: (2021)

Doravirine and Its Potential in the Treatment of HIV: An Evidence-Based Review of the Emerging Data
par: Rock AE, et autres
Publié: (2020)

Potential benefit of dolutegravir once daily: efficacy and safety
par: Fantauzzi A, et autres
Publié: (2013)

Antiretroviral Therapy – Changes of Basic Laboratory Parameters in Hiv-Infected Bulgarian Patients
par: Stojanova Yancheva Nina
Publié: (2015)

APPLICATION OF HIGH-PERFORMANCE THIN-LAYER CHROMATOGRAPHIC METHOD FOR THE SIMULTANEOUS DETERMINATION OF LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE IN PHARMACEUTICAL DOSAGE FORM
par: CHANDRA,P, et autres
Publié: (2011)

Incidence and Predictors of Initial Antiretroviral Therapy Regimen Change Among HIV-Infected Adults Receiving Antiretroviral Therapy at Arba Minch General Hospital, Southern Ethiopia
par: Gebremichael MA, et autres
Publié: (2020)

Dyslipidemia and Associated Factors Among Adult Patients on Antiretroviral Therapy in Armed Force Comprehensive and Specialized Hospital, Addis Ababa, Ethiopia
par: Kemal A, et autres
Publié: (2020)

Exploring Self-Management of Adults Living with HIV on Antiretroviral Therapy in North-West Ethiopia: Qualitative Study
par: Areri H, et autres
Publié: (2020)

Evaluation of the Sociodemographic, Behavioral and Clinical Influences on Complete Antiretroviral Therapy Adherence Among HIV-Infected Adults Receiving Medical Care in Houston, Texas
par: Sok P, et autres
Publié: (2021)

Antiretroviral Treatment Failure and Associated Factors Among HIV-Infected Children on Antiretroviral Therapy: A Retrospective Study
par: Getawa S, et autres
Publié: (2021)

Adherence to Antiretroviral Treatment Among People Who Started Treatment on the Same-Day of HIV Diagnosis in Ethiopia: A Multicenter Observational Study
par: Ahmed I, et autres
Publié: (2021)

Antiretroviral Therapy and Retention in Care Experiences and Needs of Adolescents Living with HIV in Southern Ethiopia
par: Tunje A, et autres
Publié: (2021)

Patient Satisfaction with HIV and AIDS Services in Mizan-Tepi University Teaching Hospital, Southwest Ethiopia
par: Nigussie T, et autres
Publié: (2020)

Trends, treatment outcomes, and determinants for attrition among adult patients in care at a large tertiary HIV clinic in Nairobi, Kenya: a 2004–2015 retrospective cohort study
par: Mecha JO, et autres
Publié: (2018)

Antiretroviral Therapy-Associated Metabolic Complications: Review of the Recent Studies
par: Thet D, et autres
Publié: (2020)

Serum Lipid Profiles of Patients Taking Efavirenz-Based Antiretroviral Regimen Compared to Ritonavir-Boosted Atazanavir with an Optimized Background at Zewditu Memorial Hospital, Addis Ababa, Ethiopia
par: Muche Belete A, et autres
Publié: (2021)

Mother-to-Child Transmission of HIV and Its Predictors Among HIV-Exposed Infants at an Outpatient Clinic for HIV/AIDS in Vietnam
par: Nguyen RN, et autres
Publié: (2020)

Influence of Lost to Follow Up from Antiretroviral Therapy Among Retroviral Infected Patients at Tuberculosis Centers in Public Hospitals of Benishangul-Gumuz, Ethiopia
par: Degavi G
Publié: (2021)

Patient Reported Central Nervous System Adverse Events of Efavirenz-Based Antiretroviral Therapy in People Living with HIV in Northwest Ethiopia
par: Muche EA, et autres
Publié: (2020)

Reply to Das and Berkhout, “How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir”
par: Isabelle Malet, et autres
Publié: (2018)

Safety and effectiveness of switching to Abacavir/Lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS)
par: Z. C. Lim, et autres
Publié: (2021)

Prevalence of Opportunistic Intestinal Parasitic Infections Among HIV/AIDS Patients Before and After Commencement of Antiretroviral Treatment at Felege Hiwot Referral Hospital: A Follow-up Study
par: Getachew T, et autres
Publié: (2021)

Regulatory T cell subsets in peripheral blood of HIV-infected patients with discordant response to antiretroviral therapy
par: L. B. Korolevskaya, et autres
Publié: (2020)

First-line antiretroviral treatment failure and associated factors in HIV patients at University of Gondar Teaching Hospital, Gondar, Northwest Ethiopia
par: Ayalew MB, et autres
Publié: (2016)

Incidence and Predictors of Severe Adverse Drug Reaction Among Patients on Antiretroviral Therapy in Tigray, Ethiopia: A Retrospective Cohort Study
par: Gebremeskel TG, et autres
Publié: (2021)

Attrition and Its Predictors Among Adults Receiving First-Line Antiretroviral Therapy in Woldia Town Public Health Facilities, Northeast Ethiopia: A Retrospective Cohort Study
par: Dejen D, et autres
Publié: (2021)